These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 24131355)
1. Development of thiolated poly(acrylic acid) microparticles for the nasal administration of exenatide. Millotti G; Vetter A; Leithner K; Sarti F; Shahnaz Bano G; Augustijns P; Bernkop-Schnürch A Drug Dev Ind Pharm; 2014 Dec; 40(12):1677-82. PubMed ID: 24131355 [TBL] [Abstract][Full Text] [Related]
2. Thiomers: development and in vitro evaluation of a peroral microparticulate peptide delivery system. Krauland AH; Bernkop-Schnürch A Eur J Pharm Biopharm; 2004 Mar; 57(2):181-7. PubMed ID: 15018973 [TBL] [Abstract][Full Text] [Related]
3. Oral peptide delivery: in-vitro evaluation of thiolated alginate/poly(acrylic acid) microparticles. Greimel A; Werle M; Bernkop-Schnürch A J Pharm Pharmacol; 2007 Sep; 59(9):1191-8. PubMed ID: 17883889 [TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of microparticles from thiolated polymers via air jet milling. Hoyer H; Schlocker W; Krum K; Bernkop-Schnürch A Eur J Pharm Biopharm; 2008 Jun; 69(2):476-85. PubMed ID: 18294828 [TBL] [Abstract][Full Text] [Related]
5. Nasal delivery of antisense oligonucleotides: in vitro evaluation of a thiomer/glutathione microparticulate delivery system. Vetter A; Bernkop-Schnürch A J Drug Target; 2010 May; 18(4):303-12. PubMed ID: 19947818 [TBL] [Abstract][Full Text] [Related]
6. Safety assessment of thiolated polymers: effect on ciliary beat frequency in human nasal epithelial cells. Palmberger TF; Augustijns P; Vetter A; Bernkop-Schnürch A Drug Dev Ind Pharm; 2011 Dec; 37(12):1455-62. PubMed ID: 21635138 [TBL] [Abstract][Full Text] [Related]
7. Thiolated polycarbophil as an adjuvant for permeation enhancement in nasal delivery of antisense oligonucleotides. Vetter A; Martien R; Bernkop-Schnürch A J Pharm Sci; 2010 Mar; 99(3):1427-39. PubMed ID: 19708062 [TBL] [Abstract][Full Text] [Related]
8. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa. Dünnhaupt S; Barthelmes J; Hombach J; Sakloetsakun D; Arkhipova V; Bernkop-Schnürch A Int J Pharm; 2011 Apr; 408(1-2):191-9. PubMed ID: 21295123 [TBL] [Abstract][Full Text] [Related]
9. Insulin delivery through nasal route using thiolated microspheres. Nema T; Jain A; Jain A; Shilpi S; Gulbake A; Hurkat P; Jain SK Drug Deliv; 2013; 20(5):210-5. PubMed ID: 23495666 [TBL] [Abstract][Full Text] [Related]
10. Matrix tablets based on thiolated poly(acrylic acid): pH-dependent variation in disintegration and mucoadhesion. Guggi D; Marschütz MK; Bernkop-Schnürch A Int J Pharm; 2004 Apr; 274(1-2):97-105. PubMed ID: 15072786 [TBL] [Abstract][Full Text] [Related]
11. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization. Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322 [TBL] [Abstract][Full Text] [Related]
13. Nasal delivery of human growth hormone: in vitro and in vivo evaluation of a thiomer/glutathione microparticulate delivery system. Leitner VM; Guggi D; Krauland AH; Bernkop-Schnürch A J Control Release; 2004 Nov; 100(1):87-95. PubMed ID: 15491813 [TBL] [Abstract][Full Text] [Related]
14. A comprehensive in vitro and in vivo evaluation of thiolated matrix tablets as a gastroretentive delivery system. Senyigit ZA; Vetter A; Guneri T; Bernkop-Schnürch A Drug Deliv; 2011 Aug; 18(6):405-14. PubMed ID: 21463156 [TBL] [Abstract][Full Text] [Related]
15. In vitro characterization of insulin containing thiomeric microparticles as nasal drug delivery system. Deutel B; Laffleur F; Palmberger T; Saxer A; Thaler M; Bernkop-Schnürch A Eur J Pharm Sci; 2016 Jan; 81():157-61. PubMed ID: 26517960 [TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of the potential of thiomers for the nasal administration of Leu-enkephalin. Bernkop-Schnürch A; Obermair K; Greimel A; Palmberger TF Amino Acids; 2006 Jun; 30(4):417-23. PubMed ID: 16554973 [TBL] [Abstract][Full Text] [Related]
17. Thiomers in noninvasive polypeptide delivery: in vitro and in vivo characterization of a polycarbophil-cysteine/glutathione gel formulation for human growth hormone. Leitner VM; Guggi D; Bernkop-Schnürch A J Pharm Sci; 2004 Jul; 93(7):1682-91. PubMed ID: 15176058 [TBL] [Abstract][Full Text] [Related]
18. Nasal drug delivery: Design of a novel mucoadhesive and in situ gelling polymer. Menzel C; Jelkmann M; Laffleur F; Bernkop-Schnürch A Int J Pharm; 2017 Jan; 517(1-2):196-202. PubMed ID: 27890621 [TBL] [Abstract][Full Text] [Related]
19. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies. Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983 [TBL] [Abstract][Full Text] [Related]
20. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery. Krauland AH; Guggi D; Bernkop-Schnürch A Int J Pharm; 2006 Jan; 307(2):270-7. PubMed ID: 16300914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]